Richard Whitley to Cohort Studies
This is a "connection" page, showing publications Richard Whitley has written about Cohort Studies.
Connection Strength
0.046
-
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther. 2020 10; 31(19-20):1132-1139.
Score: 0.029
-
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant. 2012 Sep; 16(6):627-37.
Score: 0.017